3-(2-甲基苯基)丙酸甲酯 | 37741-54-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-(2-甲基苯基)丙酸甲酯
• 英文名称: methyl 3-(o-tolyl)propanoate
• 英文别名: methyl 3-(2-methylphenyl)propanoate；Benzenepropanoic acid, 2-methyl-, methyl ester
• CAS: 37741-54-1
• 化学式: C₁₁H₁₄O₂
• 分子量: 178.231
• InChiKey: HVQPUZKBILZOLR-UHFFFAOYSA-N

物化性质

• 沸点：
  250.7±9.0 °C(Predicted)
• 密度：
  1.018±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-(2-甲基苯基)丙酸甲酯 在 甲醇 、 lithium aluminium tetrahydride 、 正丁基锂 、 (-)-(S)-BINAL-H 、 sodium hexamethyldisilazane 、 二异丁基氢化铝 、 potassium carbonate 、 对甲苯磺酸 作用下， 以 四氢呋喃 、 乙二醇二甲醚 、 二氯甲烷 为溶剂， 生成
  参考文献：
  名称：

  Synthesis and in vitro evaluation of human FP-receptor selective prostaglandin analogues

  摘要：

  The in vitro evaluation of a series of saturated prostaglandins revealed that compounds with omega chain aromatic rings retain nanomolar potency for the human prostaglandin F receptor (hFP receptor), exemplified by compound 8. In contrast, the double bonds are required for activity in the series with an acyclic omega chain as in PGF(2 alpha). (C) 2000 Published by Elsevier Science Ltd.

  DOI：

  10.1016/s0960-894x(00)00273-0
• 作为产物：
  描述：

  (E)-3-(2-甲基苯基)丙-2-烯酸 在 palladium on activated charcoal 甲醇 、 氢气 作用下， 以 乙酸乙酯 为溶剂， 生成 3-(2-甲基苯基)丙酸甲酯
  参考文献：
  名称：

  Synthesis and in vitro evaluation of human FP-receptor selective prostaglandin analogues

  摘要：

  The in vitro evaluation of a series of saturated prostaglandins revealed that compounds with omega chain aromatic rings retain nanomolar potency for the human prostaglandin F receptor (hFP receptor), exemplified by compound 8. In contrast, the double bonds are required for activity in the series with an acyclic omega chain as in PGF(2 alpha). (C) 2000 Published by Elsevier Science Ltd.

  DOI：

  10.1016/s0960-894x(00)00273-0

文献信息

• A recyclable CO surrogate in regioselective alkoxycarbonylation of alkenes: indirect use of carbon dioxide
  作者：P. H. Gehrtz、V. Hirschbeck、I. Fleischer

  DOI：10.1039/c5cc05012j

  日期：——

  Herein, we report a Pd-catalysed alkoxycarbonylation of alkenes based on the use of a recyclable CO₂reduction product, the crystalline and air-stableN-formylsaccharin, as a CO surrogate.

  在这里，我们报告了一种基于可回收的CO₂还原产物的Pd催化烯烃羧酯化反应，该产物是结晶的、耐空气的N-甲酰糖脲，作为CO的替代物。
• Palladium‐Catalyzed Alkoxycarbonylation of <i>sec</i> ‐Benzylic Ethers
  作者：Carolin Schneider、Ralf Jackstell、Bert U. W. Maes、Matthias Beller

  DOI：10.1002/ejoc.201901592

  日期：2020.2.28

  An alkoxycarbonylation reaction protocol for the synthesis of 3‐arylpropionate esters starting from sec‐benzylic ethers and demonstration of a comparable reaction behavior to established olefin, alcohol, or aryl halide systems.

  从仲苄基醚开始合成3-芳基丙酸酯的烷氧基羰基化反应方案，并证明了与已建立的烯烃，醇或芳基卤化物体系具有可比的反应行为。
• Quantitative Structure–Activity Relationships of Pine Weevil Antifeedants, a Multivariate Approach
  作者：Kerstin Sunnerheim、Anneli Nordqvist、Göran Nordlander、Anna-Karin Borg-Karlson、C. Rickard Unelius、Björn Bohman、Henrik Nordenhem、Claes Hellqvist、Anders Karlén

  DOI：10.1021/jf070014p

  日期：2007.11.1

  compounds screened for activity, 9 phenylpropanoates, 3 cinnamates, and 4 benzoates were found to be highly active antifeedants. To understand the structure-activity relationships of these compounds, a multivariate analysis study was performed. A number of molecular and substituent descriptors were calculated and correlated to results from two-choice feeding tests with H. abietis. Three local models were developed

  在松树象鼻虫（Hylobius abietis）上测试了主要是苯丙酸酯，肉桂酸酯和苯甲酸酯的拒食活性。在筛选出活性的105种化合物中，发现9种苯基丙酸酯，3种肉桂酸酯和4种苯甲酸酯是高活性的拒食剂。为了了解这些化合物的构效关系，进行了多变量分析研究。计算了许多分子和取代基描述子，并将其与由过双歧杆菌进行的二选饲喂试验的结果相关联。建立了三个具有良好内部预测能力的局部模型。外部测试集显示出中等预测性。通常，低极性，小尺寸和高亲脂性是具有良好拒食活性的化合物的特征。
• DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS
  申请人：Matsuyama Hironori

  公开号：US20100004438A1

  公开（公告）日：2010-01-07

  An object of the present invention is to provide a medicinal drug much improved in anti tumor activity and excellent in safety. According to the present invention, there is provided a medicinal drug containing a compound represented by the following general formula (1) or a salt thereof as an active ingredient: [Formula 1] wherein X 1 represents a nitrogen atom or a group —CH═, R 1 represents a group -Z-R 6 , in which Z represents a group —CO—, a group —CH(OH)— or the like, R 6 represents a 5- to 15-membered monocyclic, dicyclic or tricyclic saturated or unsaturated heterocyclic group having 1 to 4 nitrogen atoms, oxygen atoms or sulfur atoms, R 2 represents a hydrogen atom or a halogen atom, Y represents a group —O—, a group —CO—, a group —CH(OH)— or a lower alkylene group, and A represents [Formula 2] wherein R 3 represents a hydrogen atom, a lower alkoxy group or the like, p represents 1 or 2, R 4 represents an imidazolyl lower alkyl group or the like.

  本发明的一个目的是提供一种在抗肿瘤活性方面大大改进且安全性优异的药物。根据本发明，提供了一种包含以下一般式（1）所表示的化合物或其盐作为活性成分的药物：[式1]其中X1代表氮原子或基团—CH═，R1代表一个基团-Z-R6，其中Z代表基团—CO—，基团—CH(OH)—或类似的基团，R6代表一个含有1至4个氮原子、氧原子或硫原子的5至15个成员的单环、双环或三环饱和或不饱和杂环基团，R2代表氢原子或卤原子，Y代表基团—O—，基团—CO—，基团—CH(OH)—或低碳烷基基团，A代表[式2]其中R3代表氢原子、低碳氧基基团或类似基团，p代表1或2，R4代表咪唑基低碳基团或类似基团。
• Reduction of Electron‐Deficient Alkenes Enabled by a Photoinduced Hydrogen Atom Transfer
  作者：Natalia A. Larionova、Jun Miyatake Ondozabal、Xacobe C. Cambeiro

  DOI：10.1002/adsc.202000751

  日期：2021.1.19

  Direct hydrogen atom transfer from a photoredox‐generated Hantzsch ester radical cation to electron‐deficient alkenes has enabled the development of an efficient formal hydrogenation under mild, operationally simple conditions. The HAT‐driven mechanism is supported by experimental and computational studies. The reaction is applied to a variety of cinnamate derivatives and related structures, irrespective

  氢原子从光氧化还原产生的Hantzsch酯自由基阳离子直接转移到缺电子的烯烃中，使得在温和，操作简单的条件下有效的正式加氢反应得以发展。HAT驱动的机制得到了实验和计算研究的支持。该反应适用于各种肉桂酸酯衍生物和相关结构，无论芳环中是否存在给电子或吸电子取代基且具有良好的官能团相容性。